Advisory Board
Bringing science and development to the forefront of decision-making
With decades of experience in clinical practice, pharmacy, biotechnology, immunology, and regulation, our advisory board provides valuable insights and expertise that guide our research and development efforts
ALGIRDAS LUKOSEVICIUS, PharmD
Global business executive expert at international finance, government, medical groups, consumer, IT, legal and manufacturing, pharmaceuticals, biotech, medical device, non-profit, venture capital, private equity. Managed >200 M USD.
Prof. JANIS ANCANS
Former expert at European Medicines Agency at non-clinical evaluation. Connects with healthcare regulatory bodies, ensuring KELI's products meet EU EMA and US FDA standards
Prof. RENALDAS URNIEZIUS
Two patents assignee. Upstream and downstream bioprocess experties. Leads pilot and large-scale production, working with cell processing specialists to ensure GMP compliance
MARCO EIJKEN, PhD
An associate professor at Aarhus University Hospital. Specializes in renal medicine. His work involves pre-clinical studies in mesenchymal stromal cell therapy and the production of clinical-grade mesenchymal stromal cells